Recent Mergers Under Investigation: Watch Out for Shareholder Rights

Shareholder Alert: Mergers in Focus for Class Action Investigation

In a critical move for shareholders across the country, the M&A Class Action Firm, Monteverde & Associates PC led by attorney Juan Monteverde, is actively investigating the mergers involving significant companies such as First Savings Financial Group (FSFG), Metsera Inc. (MTSR), Verint Systems Inc. (VRNT), and Merus N.V. (MRUS). This investigation highlights the importance of safeguarding shareholder interests during these transformative corporate transactions.

First Savings Financial Group

First Savings Financial Group is exploring a sale to First Merchants Corporation, where shareholders will see their holdings converted into shares of the acquiring entity. Specifically, each outstanding share of First Savings common stock will be exchanged for 0.85 shares of First Merchants common stock. Shareholders are advised to stay vigilant as the shareholder vote for this merger is slated for December 19, 2025. Those with investments have the opportunity to learn more about their rights and actions they can take, ensuring they do not miss out on any potential benefits.

Metsera Inc. and Pfizer Inc.

In another significant transaction, Metsera Inc. is set to be acquired by Pfizer Inc. This deal promises a cash payout of $47.50 per share for Metsera shareholders, in addition to contingent value rights that could yield additional payments depending on regulatory milestones. The urgency for shareholders is palpable, with the vote scheduled for November 13, 2025. Engaging with the upcoming vote could provide a pathway to maximize shareholder returns.

Verint Systems and Thoma Bravo

Verint Systems Inc. is also under the scrutiny of Monteverde & Associates as it moves forward with its sale to Thoma Bravo. Under the terms of the acquisition, Verint shareholders will receive a cash payment of $20.50 per share. With the vote approaching on November 18, 2025, shareholders need to review the implications of this merger and consider their positions.

Merus N.V. and GEnmad A/S

Lastly, Merus N.V. is set for acquisition by GEnmad A/S, offering stockholders $97.00 in cash per share. The tender offer expires soon, on December 11, 2025, which emphasizes the need for shareholders to act swiftly to safeguard their investments.

Protecting Shareholder Rights

Juan Monteverde emphasizes the key questions all shareholders should ask: "Does your law firm handle class actions and appear in court? What is your firm’s track record of recovering funds for shareholders? What recent cases have you taken on?" These inquiries are crucial for shareholders to ensure their rights are protected and that they receive fair compensation during these mergers.

Monteverde & Associates has built a reputation as a national leader in class action securities cases, boasting a strong history in various court outcomes, including the U.S. Supreme Court. With their headquarters located in the iconic Empire State Building in New York, they are well-equipped to assist shareholders during merger transactions.

For shareholders of the mentioned companies, it's essential to remain informed and proactive in their rights and options. This investigation by the M&A Class Action Firm represents a critical opportunity for shareholders to engage, protect their assets, and ensure they receive the financial outcomes they deserve from these high-stakes mergers.

If you own common stock in these companies and wish to learn more about your options, visit Monteverde Law or contact attorney Juan Monteverde directly at [email protected] or call (212) 971-1341. Remember, acting diligently now can make all the difference in ensuring your interests are adequately represented.